We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Structure–function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum’s disease.
- Authors
Mukherji, Mridul; Chien, Winnie; Kershaw, Nadia J.; Clifton, Ian J.; Schofield, Christopher J.; Wierzbicki, Anthony S.; Lloyd, Matthew D.
- Abstract
Refsum’s disease is a neurological syndrome characterized by adult-onset retinitis pigmentosa, anosmia, sensory neuropathy and phytanic acidaemia. Many cases are caused by mutations in peroxisomal oxygenase phytanoyl-CoA 2-hydroxylase (PAHX) which catalyses the initial α -oxidation step in the degradation of phytanic acid. Both pro and mature forms of recombinant PAHX were produced in Escherichia coli , highly purified, and shown to have a requirement for iron(II) as a co-factor and 2-oxoglutarate as a co-substrate. Sequence analysis in the light of crystallographic data for other members of the 2-oxoglutarate-dependent oxygenase super-family led to secondary structural predictions for PAHX, which were tested by site-directed mutagenesis. The H175A and D177A mutants did not catalyse hydroxylation of phytanoyl-CoA, consistent with their assigned role as iron(II) binding ligands. The clinically observed P29S, Q176K, G204S, N269H, R275Q and R275W mutants were assayed for both 2-oxoglutarate and phytanoyl-CoA oxidation. The P29S mutant was fully active, implying that the mutation resulted in defective targeting of the protein to peroxisomes. Mutation of Arg-275 resulted in impaired 2-oxoglutarate binding. The Q176K, G204S and N269H mutations caused partial uncoupling of 2-oxoglutarate conversion from phytanoyl-CoA oxidation. The results demonstrate that the diagnosis of Refsum’s disease should not solely rely upon PAHX assays for 2-oxoglutarate or phytanoyl-CoA oxidation.
- Subjects
PEROXISOMAL disorders; GENETIC mutation; DIAGNOSIS
- Publication
Human Molecular Genetics, 2001, Vol 10, Issue 18, p1971
- ISSN
0964-6906
- Publication type
Article
- DOI
10.1093/hmg/10.18.1971